Clinical Trials List
2023-01-30 - 2025-10-06
Phase III
Not yet recruiting8
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 廖偉志 Division of General Internal Medicine
- Chen Chia-Hung Division of General Internal Medicine
- 陳鴻仁 Division of General Internal Medicine
- Chih-Yen Tu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 林定佑 Division of Thoracic Medicine
- Chih-Hsi Kuo Division of Thoracic Medicine
- Chih-Liang Wang Division of Thoracic Medicine
- 柯皓文 Division of Thoracic Medicine
- Cheng-Ta Yang Division of Thoracic Medicine
- 枋岳甫 Division of Thoracic Medicine
- Ping-Chih Hsu Division of Thoracic Medicine
- 邱立忠 Division of Thoracic Medicine
- Chih-Hung Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Thoracic Medicine
- 蔡政軒 Division of Thoracic Medicine
- Chian-Wei Chen Division of Thoracic Medicine
- Po-Lan Su Division of Thoracic Medicine
- Chin-Wei Kuo Division of Thoracic Medicine
- Seu-Chun Yang Division of Thoracic Medicine
- Chun-Hui Lee Division of Thoracic Medicine
- Wu-Chou Su Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- YEN-TING LIN
- 吳尚俊 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- Jih-Hsiang Lee
- Chong-Jen Yu Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 陳祐易 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- 李柏昕 Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chia-I Shen Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- Heng-Sheng Chao Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
580 participants
